Search Results

There are 16403 results for: content related to: Impact of hepatitis B therapy on the long-term outcome of liver disease

  1. You have free access to this content
    Natural history of chronic hepatitis B virus infection and long-term outcome under treatment

    Liver International

    Volume 29, Issue s1, January 2009, Pages: 100–107, Yun-Fan Liaw

    Version of Record online : 21 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01941.x

  2. You have free access to this content
    Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion

    Liver International

    Volume 30, Issue 4, April 2010, Pages: 512–520, George K. K. Lau

    Version of Record online : 19 JAN 2010, DOI: 10.1111/j.1478-3231.2009.02198.x

  3. You have free access to this content
    Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon

    Liver International

    Volume 30, Issue 5, May 2010, Pages: 657–668, Patrick Marcellin, Joseph Sung and Teerha Piratvisuth

    Version of Record online : 15 FEB 2010, DOI: 10.1111/j.1478-3231.2010.02207.x

  4. You have free access to this content
    Quantification of hepatitis B surface antigen: a new concept for the management of chronic hepatitis B

    Liver International

    Volume 31, Issue s1, January 2011, Pages: 122–128, Rami Moucari and Patrick Marcellin

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02390.x

  5. You have free access to this content
    Current management of hepatitis B virus infection before and after liver transplantation

    Liver International

    Volume 29, Issue 9, October 2009, Pages: 1294–1305, George V. Papatheodoridis, Evangelos Cholongitas, Athanasios J. Archimandritis and Andrew K. Burroughs

    Version of Record online : 10 JUL 2009, DOI: 10.1111/j.1478-3231.2009.02085.x

  6. You have free access to this content
    Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues

    Liver International

    Volume 31, Issue s1, January 2011, Pages: 95–103, George V. Papatheodoridis

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02392.x

    Corrected by:

    ERRATA

    Vol. 31, Issue 5, 748, Version of Record online: 22 MAR 2011

  7. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

    Liver International

    Volume 25, Issue 3, June 2005, Pages: 472–489, Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata and for the Asian-Pacific consensus update working party on chronic hepatitis B

    Version of Record online : 21 MAY 2005, DOI: 10.1111/j.1478-3231.2005.01134.x

  8. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Ronald L Koretz, Maria Pleguezuelo, Vasiliki Arvaniti, Pilar Barrera Baena, Ruben Ciria, Kurinchi Selvan Gurusamy, Brian R Davidson and Andrew K Burroughs

    Published Online : 31 JAN 2013, DOI: 10.1002/14651858.CD003617.pub2

  9. You have free access to this content
    HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues

    Liver International

    Volume 29, Issue s1, January 2009, Pages: 130–132, Pietro Lampertico and Massimo Colombo

    Version of Record online : 21 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01931.x

  10. You have free access to this content
    Current issues in the management of paediatric viral hepatitis

    Liver International

    Volume 30, Issue 1, January 2010, Pages: 5–18, Latifa T. F. Yeung and Eve A. Roberts

    Version of Record online : 19 OCT 2009, DOI: 10.1111/j.1478-3231.2009.02145.x

  11. Natural and iatrogenic variation in hepatitis B virus

    Reviews in Medical Virology

    Volume 9, Issue 3, July/September 1999, Pages: 183–209, S. L. Ngui, R. Hallet and C. G. Teo

    Version of Record online : 31 AUG 1999, DOI: 10.1002/(SICI)1099-1654(199907/09)9:3<183::AID-RMV248>3.0.CO;2-P

  12. You have free access to this content
    British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010

    HIV Medicine

    Volume 11, Issue 1, January 2010, Pages: 1–30, G Brook, J Main, M Nelson, S Bhagani, E Wilkins, C Leen, M Fisher, Y Gilleece, R Gilson, A Freedman, R Kulasegaram, K Agarwal, C Sabin, C Deacon-Adams and on behalf of the BHIVA Viral Hepatitis Working Group

    Version of Record online : 8 DEC 2009, DOI: 10.1111/j.1468-1293.2009.00781.x

  13. You have free access to this content
    Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?

    Liver International

    Volume 31, Issue s1, January 2011, Pages: 78–84, Milan J. Sonneveld and Harry L. A. Janssen

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02384.x

  14. Direct-acting antivirals for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz and Christian Gluud

    Published Online : 6 JUN 2017, DOI: 10.1002/14651858.CD012143.pub2

  15. Hepatitis B and C in liver transplantation: new strategies to combat the enemies

    Reviews in Medical Virology

    Volume 23, Issue 3, May 2013, Pages: 172–193, Susanne Beckebaum, Iyad Kabar and Vito R. Cicinnati

    Version of Record online : 13 DEC 2012, DOI: 10.1002/rmv.1734

  16. The race for interferon-free HCV therapies: a snapshot by the spring of 2012

    Reviews in Medical Virology

    Volume 22, Issue 6, November 2012, Pages: 392–411, Erik De Clercq

    Version of Record online : 30 AUG 2012, DOI: 10.1002/rmv.1727

  17. Therapy of chronic hepatitis B: current challenges and opportunities

    Journal of Viral Hepatitis

    Volume 9, Issue 6, November 2002, Pages: 393–399, Y.-F. Liaw

    Version of Record online : 13 NOV 2002, DOI: 10.1046/j.1365-2893.2002.00388.x

  18. Changes in serum hepatitis B e antigen (HBeAg) levels associated with the emergence of YMDD mutants in HBeAg non-seroconverted patients during lamivudine therapy

    Liver International

    Volume 27, Issue 10, December 2007, Pages: 1349–1355, Yi-Hao Yen, Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, Chun-Mei Wu, Chao-Hung Hung, Po-lin Tseng, Tsung-Hui Hu, Chi-Sin Changchien and Chuan-Mo Lee

    Version of Record online : 20 NOV 2007, DOI: 10.1111/j.1478-3231.2007.01609.x

  19. Use of Dried Blood Spot Samples in HCV-, HBV-, and Influenza-Related Epidemiological Studies

    Dried Blood Spots: Applications and Techniques

    Harleen Gakhar, Mark Holodniy, Pages: 95–113, 2014

    Published Online : 13 JUN 2014, DOI: 10.1002/9781118890837.ch8

  20. You have free access to this content
    The role of HBsAg quantification for monitoring natural history and treatment outcome

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 125–132, Michelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah and Patrick Marcellin

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12075